...
首页> 外文期刊>The journal of immunology >Self-reactive T cell hybridomas and tolerance. Same range of antigen dose dependence but higher numbers of self-reactive T cell hybridomas from mice in which self-tolerance has been broken by antiserum treatment.
【24h】

Self-reactive T cell hybridomas and tolerance. Same range of antigen dose dependence but higher numbers of self-reactive T cell hybridomas from mice in which self-tolerance has been broken by antiserum treatment.

机译:自身反应性T细胞杂交瘤和耐受性。抗原剂量依赖性的范围相同,但来自小鼠的自身反应性T细胞杂交瘤数量更多,其中通过抗血清治疗破坏了自身耐受性。

获取原文

摘要

Mechanisms of self-tolerance of 4-hydroxyphenylpyruvate dioxygenase (HPPD) are explored. It is well established that negative selection based on TCR affinity occurs in the thymus. We have investigated the frequency with which self-reactive T cell hybridomas can be obtained in relation to self-tolerance. Mice immunized with the self-form of HPPD gave rise to T cell hybridomas that were able to recognize self-protein and a synthetic peptide representing the T cell epitope, at higher Ag concentration than was necessary for recognition of allo-protein. The efficiency of negative selection was then reduced by treating neonatal mice with anti-HPPD antiserum. This reduced T cell tolerance of the self-protein, as judged by in vitro proliferation, and enabled self-reactive T cell hybridomas to be generated at a higher frequency. However, the Ag concentration requirements of these hybridomas for the self-protein and the self-peptide remained unaltered. The possibility that these findings reflect an auxiliary mechanism of self-tolerance based on frequencies of self-reactive T cells is discussed.
机译:探索了4-羟苯基丙酮酸双加氧酶(HPPD)的自我耐受机制。众所周知,在胸腺中会发生基于TCR亲和力的阴性选择。我们已经研究了与自我耐受性相关的获得自我反应性T细胞杂交瘤的频率。用HPPD自身形式免疫的小鼠产生了能够识别自身蛋白和代表T细胞表位的合成肽的T细胞杂交瘤,其Ag浓度高于识别同种蛋白所需的Ag浓度。然后通过用抗HPPD抗血清治疗新生小鼠来降低阴性选择的效率。通过体外增殖判断,这降低了自身蛋白的T细胞耐受性,并使自反应性T细胞杂交瘤的产生频率更高。然而,这些杂交瘤对自身蛋白和自身肽的Ag浓度要求保持不变。讨论了这些发现反映了基于自我反应性T细胞频率的自我耐受的辅助机制的可能性。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号